Senior ministers and MPs have warned that the UK’s recent agreements with Donald Trump are dangerously fragile, after it emerged that the flagship deal to avoid US tariffs on pharmaceuticals has no detailed legal text beyond high-level political statements. The “milestone” UK–US pharmaceuticals agreement announced earlier this month, under which the NHS is expected to pay more for medicines in exchange for zero tariffs on exports to the US, currently rests on little more than...










